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Viral infection activates transcription factors IRF3
and NF-kB, which collaborate to induce type I inter-
ferons (IFNs). Here, we identified glycogen synthase
kinase 3b (GSK3b) as an important regulator for
virus-triggered IRF3 and NF-kB activation, IFN-b
induction, and cellular antiviral response. Overex-
pression of GSK3b potentiated virus-induced activa-
tion of IRF3 and transcription of the IFNB1 gene,
whereas reduced expression or deletion of GSK3b
impaired virus-induced IRF3 and NF-kB activation,
transcription of the IFNB1 gene, as well as cellular
antiviral response. GSK3b physically associated
with the kinase TBK1 in a viral infection-dependent
manner. GSK3b promoted TBK1 self-association
and autophosphorylation at Ser172, which is critical
for virus-induced IRF3 activation and IFN-b induc-
tion. The effect of GSK3b on virus-induced signaling
is independent of its kinase activity. Our findings
suggest that GSK3b plays important roles in virus-
triggered IRF3 activation by promoting TBK1 activa-
tion and provide new insights to the molecular mech-
anisms of cellular antiviral response.
INTRODUCTION
Host pattern-recognition receptors (PRRs) of the innate immune
system recognize invading viruses and initiate a series of
signaling events leading to production of type I interferons
(IFNs) and proinflammatory cytokines (Akira et al., 2006; Hiscott,
2007). Type I IFNs further activate downstream signaling
pathways that lead to transcriptional induction of a wide range
of antiviral genes. The antiviral gene products collaborate to
elicit cellular antiviral response through various mechanisms
(Levy and Garcı´a-Sastre, 2001; Randall and Goodbourn, 2008).
Transcriptional induction of many type I IFN genes requires
cooperation of transcription factors such as IFN-regulatory
factor 3 (IRF3), IRF7, NF-kB, and ATF2-c-Jun, which bind to
the conserved enhancer elements of the type I IFN gene
promoters and initiate their transcription (Honda et al., 2006).
Understanding the signaling pathways of virus-triggered
induction of type I IFNs is in progress. Viral infection and replica-878 Immunity 33, 878–889, December 22, 2010 ª2010 Elsevier Inc.tion generates pathogen-associated molecular patterns
(PAMPs) such as viral 50-phosphorylated double-stranded RNA
(dsRNA), single-stranded RNA (ssRNA), 50-triphosphate
panhandle RNA, and viral double-stranded DNA (dsDNA), which
are sensed by cellular PRRs (Koyama et al., 2008). Among the
PRRs, Toll-like receptors (TLRs) and RIG-I-like receptors
(RLRs) are demonstrated to be membrane associated and cyto-
plasmic sensors of viral RNAs, respectively. For example, TLR3,
TLR7, and TLR8 recognize dsRNA or ssRNA at the membrane of
endosomes. RIG-I binds to short dsRNA and 50-triphosphate
panhandle RNA, whereas MDA5, another member of RLRs,
recognizes long dsRNA (Ishii et al., 2008; Kato et al., 2008;
Yoneyama and Fujita, 2008). Recently, it has been reported
that dA:dT-rich dsDNA is transcribed into dsRNA, which is
subsequently recognized by RIG-I (Ablasser et al., 2009; Chiu
et al., 2009).
Upon binding to viral RNA, RIG-I undergoes conformational
change and is recruited to the mitochondrial adaptor protein
VISA (also known as MAVS, IPS-1, and Cardif) (Kawai et al.,
2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005).
VISA interacts with TNF receptor associated factor 6 (TRAF6)
through its conserved TRAF-binding motifs to activate the IKK
(IkB kinase) complex, which phosphorylates IkBa (Inhibitory
kappa B alpha), leading to the release and activation of NF-kB.
VISA is also associated with MITA (also known as STING)
through its transmembrane domain. MITA acts as a scaffolding
protein to recruit the kinase TBK1 to the VISA-associated
signaling complex and promotes TBK1-IRF3 association,
leading to phosphorylation and activation of IRF3 (Ishikawa
and Barber, 2008; Zhong et al., 2008). However, how TBK1 itself
is activated remains less clear.
Glycogen synthase kinase 3b (GSK3b) has been identified as
a serine-threonine (ser-thr) kinase that phosphorylates and
inactivates glycogen synthase. GSK3b is ubiquitously expressed
in various tissues and organs in a constitutively active form.
Previous studies have demonstrated that GSK3b is involved in
various signaling pathways and regulates many cellular activi-
ties, such as metabolism, cell cycle, transcription regulation,
vesicular transport, neuronal function, oncogenesis, and
development (Jope and Johnson, 2004). GSK3b is also involved
in TLR-mediated production of pro- or anti-inflammatory cyto-
kines. For example, knockdown of GSK3b or treatment with
GSK3b inhibitors reduces TLR4- and TLR2-mediated release
of interleukin-12 (IL-12) and increases the secretion of IL-10,
respectively, indicating that GSK3b is a crucial regulator for
the balance between pro- and anti-inflammatory cytokines
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negatively regulates TLR4-mediated IFN-b production by regu-
lating c-Jun expression (Wang et al., 2008). However, whether
and how GSK3b is involved in virus-triggered signaling is
unknown.
In this study, we found that GSK3bwas essential for virus-trig-
gered IRF3 and NF-kB activation, IFN-b induction, and cellular
antiviral response. GSK3b promoted TBK1 dimerization and/or
oligomerization and autophosphorylation at Ser172 independent
of the kinase activity of GSK3b. Our findings provide insights to
the molecular mechanisms of virus-triggered TBK1 activation,
a critical step in virus-trigggered type I IFN induction and cellular
antiviral response.
RESULTS
Overexpression of GSK3b Potentiates Virus-Triggered
Activation of IRF3 and Transcription of IFNB1
GSK3b is involved in differential regulation of TLR-mediated
production of pro- or anti-inflammatory cytokines and negatively
regulates LPS-induced IFN-b production (Martin et al., 2005).
Because TLR- and RLR-mediated signaling pathways share
a number of key components, we examined whether GSK3b is
also involved in regulation of virus-triggered and RLR-mediated
signaling. In reporter assays, overexpression of GSK3b but not
its homolog GSK3a significantly potentiated Sendai virus
(SeV)-triggered activation of the IFN-b promoter in human
embryonic 293 cells (Figure 1A). RT-PCR experiments indicated
that overexpression of GSK3b potentiated transcription of virus-
induced downstream genes, such as IFNB1, CCL5, and ISG15
(Figure 1B). Because the transcription factor IRF3 is critically
involved in virus-triggered induction of type I IFN genes, we
determined the effect of GSK3b on virus-triggered activation of
IRF3. Overexpression of GSK3b but not GSK3a potentiated
SeV-induced ISRE (interferon-stimulated response element)
activation (Figure 1C) and IRF3 dimerization (Figure 1D), which
are hallmarks of IRF3 activation. These results suggest that
GSK3b potentiates virus-triggered activation of IRF3 as well as
transcription of the IFNB1 gene.
Because the kinase activity of GSK3b is important for its func-
tions in various signaling pathways, we next examined whether
the effect of GSK3b on virus-triggered IRF3 activation is depen-
dent on its kinase activity. Mutation of Ser9 of GSK3b to alanine
(S9A) confers its constitutive kinase activity, whereasmutation of
the ATP binding residue Lys85 of GSK3b to alanine (K85A) abol-
ishes its kinase activity (Jope and Johnson, 2004). We found that
both the kinase constitutively active mutant GSK3b(S9A) and the
kinase inactive mutant GSK3b(K85A) enhanced SeV-induced
dimerization of IRF3 (Figure 1D), as well as activation of ISRE
(Figure 1E) and the IFN-b promoter (Figure 1F) to amounts
comparable to wild-type GSK3b. These results suggest that
the effect of GSK3b on virus-triggered signaling is independent
of its kinase activity. Consistently, GSK3b and its mutants
GSK3b(S9A) and GSK3b(K85A) enhanced activation of the
IFN-b promoter and ISRE triggered by cytoplasmic poly(I:C) (Fig-
ure S1A available online). Overexpression of GSK3b and the two
mutants also potentiated TLR3-mediated activation of the IFN-b
promoter and ISRE (Figure S1B). In reporter assays, wild-type
GSK3b, as well as GSK3b(S9A) and GSK3b(K85A), did notIpotentiate IFN-g-triggered activation of the IRF1 promoter (Fig-
ure 1G), suggesting that GSK3b plays a specific role in virus-trig-
gered IRF3 activation and IFN-b induction.
Knockdown of GSK3b Inhibits IRF3 Activation and IFNB1
Transcription
Because overexpression of GSK3b potentiated virus-triggered
induction of IFN-b, we next determined whether endogenous
GSK3b is required for virus-induced signaling. We constructed
two GSK3b-RNAi plasmids that could efficiently inhibit the
expression of tranfected and endogenous GSK3b (Figure 2A).
Both of the RNAi plasmids markedly inhibited SeV-triggered
activation of the IFN-b promoter and ISRE in reporter assays
(Figure 2B) as well as endogenous expression of IFNB1, CCL5,
and ISG15 genes in RT-PCR experiments in 293 cells (Figure 2C).
These results suggest that GSK3b plays an important role in
virus-triggered induction of IFN-b. This effect is not cell type
specific because knockdown of GSK3b also inhibited SeV-
induced activation of the IFN-b promoter in A549 and HeLa cells
(Figure S2A).
Consistently, knockdown of GSK3b markedly inhibited SeV-
induced IRF3 phosphorylation and dimerization (Figure 2D).
Knockdown of GSK3b did not significantly inhibit IFN-g-induced
activation of the IRF1 promoter (Figure 2E), suggesting that
GSK3b is specifically involved in virus-triggered IRF3 activation
and IFN-b expression.
We further determined whether GSK3b is involved in intracel-
lular dsRNA- or dsDNA-triggered signaling. Knockdown of
GSK3b markedly inhibited activation of ISRE and the IFN-b
promoter triggered by poly(I:C) and poly(dA:dT) transfected
into 293 cells (Figures 2F and 2G). Knockdown of GSK3b also in-
hibited poly(I:C)-triggered TLR3-mediated as well as LPS-
induced TLR4-mediated signaling leading to IFN-b induction
(Figure 2H; Figure S2B). These data suggest that GSK3b is
required for both RLR-mediated and TLR3- and TLR4-mediated
IRF3 activation and IFN-b induction.
Impairment of IRF3 Activation and IFN-b Induction
in GSK3b-Deficient Cells
Gsk3b gene deletion in mice results in embryonic lethality result-
ing from multifocal hemorrhagic degeneration in the livers
(Hoeflich et al., 2000). However, we obtained Gsk3b/ mouse
embryonic fibroblasts (MEFs) and examined whether virus-trig-
gered signaling is impaired in these cells. We found that SeV-
induced activation of the IFN-b promoter was severely impaired
in Gsk3b/ MEFs compared to their wild-type counterparts in
reporter assays (Figure 3A). RT-PCR experiments indicated
that SeV-induced expression of endogenous Ifnb1 gene was
impaired in Gsk3b/ MEFs (Figure 3B). Consistently, SeV-
induced ISRE activation (Figure 3C), IRF3 dimerization, and
phosphorylation (Figure 3D) were impaired in Gsk3b/ MEFs.
Reconstitution of GSK3b but not GSK3a into Gsk3b/ MEFs
by retrovirus-mediated gene transfer significantly restored
SeV-induced activation of the IFN-b promoter (Figure 3E). Simi-
larly, reconstitution of Gsk3b/ MEFs with GSK3b(K85A) and
GSK3b(S9A) also restored SeV-induced activation of the IFN-b
promoter and ISRE to degrees similar to the wild-type GSK3b
(Figure 3F). Real-time PCR experiments further confirmed that
SeV-induced transcription of Ifnb1 gene was restored inmmunity 33, 878–889, December 22, 2010 ª2010 Elsevier Inc. 879
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Figure 1. Overexpression of GSK3b Potentiates Virus-Triggered Activation of IRF3 and Transcription of the IFNB1 Gene
(A) GSK3b but not GSK3a potentiates SeV-induced activation of the IFN-b promoter. 293 cells (1 3 105) were transfected with the IFN-b promoter luciferase
plasmid (0.1 mg) and an expression plasmid for GSK3b or GSK3a (0.25 mg). 20 hr after transfection, cells were infected with SeV or left untreated for 12 hr before
luciferase assays were performed.
(B) GSK3b but not GSK3a potentiates SeV-induced transcription of endogenous IFNB1, CCL5, and ISG15 genes. 293 cells (2 3 105) were transfected with the
indicated expression plasmids (2 mg each) for 20 hr, cells were infected with SeV or left untreated for 10 hr before RT-PCR was performed.
(C) GSK3b but not GSK3a potentiates SeV-induced ISRE activation in 293 cells. The experiments were performed as in (A) except that ISRE reporter plasmid was
used.
(D) GSK3b and its mutants enhance SeV-induced dimerization of IRF3. 293 cells (23 105) were transfected with the indicated plasmids. 20 hr after transfection,
cells were infected with SeV or left uninfected for 8 hr. Cell lysates were separated by native (top) or SDS (bottom) PAGE and analyzed by immunoblots with the
indicated antibodies.
(E and F) GSK3b and its mutants potentiate SeV-induced activation of ISRE (E) and the IFN-b promoter (F). The experiments were performed as in (A).
(G) GSK3a, GSK3b, and its mutants do not potentiate IFN-g-induced activation of the IRF1 promoter. 293 cells (13 105) were transfected with the IRF1 promoter
reporter plasmid (0.1 mg) and the indicated mammalian expression plasmids (0.25 mg). 20 hr after transfection, cells were treated with IFN-g (100 ng/ml) or left
untreated. Luciferase assays were performed 12 hr after infection.
Graphs show mean ± SD, n = 3. *p < 0.05; **p < 0.01. See also Figure S1.
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GSK3b Regulates TBK1 Activity and IFN-b InductionGsk3b/ MEFs after reconstitution with wild-type GSK3b,
GSK3b(K85A), or GSK3b(S9A) (Figure 3G). In plaque assays
with Vesicular stomatitis virus (VSV), markedly higher VSV titers
were produced from Gsk3b/ MEFs than the wild-type control
cells (Figure 3H). Transfection of poly(I:C) caused antiviral
response and reduced viral titers in wild-type but not Gsk3b/
MEFs (Figure 3H). Reconstitution with GSK3b, GSK3b(K85A),
or GSK3b(S9A) restored the antiviral activity of the Gsk3b/
MEFs (Figure 3H). Thus, GSK3b is important for virus-triggered
IRF3 activation, IFN-b induction, and cellular antiviral response.880 Immunity 33, 878–889, December 22, 2010 ª2010 Elsevier Inc.These results also suggest that the kinase activity of GSK3b is
not required for its role in virus-triggered IFN-b induction and
antiviral activity.
GSK3b Regulates Virus-Triggered Signaling at the TBK1
Level
Various proteins have been reported to be involved in the virus-
triggered IRF3 activation pathway such as RIG-I, VISA, MITA,
TBK1, and IKK3. To determine the molecular order of GSK3b in
the virus-triggered IRF3 activation pathway, we examined the
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GSK3b Regulates TBK1 Activity and IFN-b Inductioneffects of reduced expression (knockdownwith RNAi) or deletion
of GSK3b on ISRE activation mediated by these molecules in
reporter assays. Reduced expression or deletion of GSK3b
inhibited RIG-I-, VISA-, MITA-, and TBK1-mediated ISRE activa-
tion. In the same experiments, ISRE activation mediated by IKK3
or IRF3(5D), a constitutive active IRF3 mutant (Lin et al., 1998),
was not markedly inhibited (Figures 4A and 4B). Because
RIG-I, VISA, and MITA act upstream whereas IRF3 acts down-
stream of TBK1, the simplest explanation from these data is
that GSK3b targets TBK1. Consistent with the notion that
TBK1 acts downstream of TRIF in the TLR3-mediated IRF3 acti-
vation pathway (Fitzgerald et al., 2003; McWhirter et al., 2004),
knockdown of GSK3b also inhibited TRIF-mediated activation
of ISRE and the IFN-b promoter (Figure 4C). Although TBK1
and IKK3 have redundant roles in certain circumstances, knock-
down of GSK3b inhibited TBK1 but not IKK3-mediated ISRE
activation (Figure 4A). Consistently, GSK3b potentiated TBK1-
but not IKK3-mediated ISRE activation (Figure 4D). In transient
transfection and coimmunoprecipitation experiments, GSK3b
interacted with TBK1 but not IKK3 (Figure 4E). Domain mapping
experiments indicated that the kinase domain of GSK3b
(aa 56–340) and the C-terminal coiled-coil containing domain
of TBK1 (aa 451–729) are required for their interaction (Figure S3).
Although the kinase domain of GSK3b could interact with TBK1,
it was not sufficient to restore SeV-induced IFN-b production in
Gsk3b/ MEFs. In the same experiments, wild-type GSK3b
but not GSK3b (aa 221–420) (which did not interact with TBK1)
restored SeV-induced IFN-b production (Figure S3). These
results suggest that GSK3b specifically targets TBK1 but not
IKK3.
We next examined whether GSK3b is physically associated
with TBK1 in untransfected cells. Endogenous coimmunopreci-
pitation experiments indicated that GSK3b did not interact with
TBK1 under physiological condition; however, their interaction
was detectable at 4 hr after SeV infection and increased to
high levels at 8 and 12 hr after SeV infection. Correspondingly,
IFN-b mRNA was markedly induced at 8 hr after SeV infection
(Figure 4F). These results suggest that GSK3b is associated
with TBK1 in a viral infection-dependent manner and this associ-
ation is correlated to virus-triggered IFN-b induction.
GSK3b Promotes TBK1 Self-Association
and Autophosphorylation
We next investigated how GSK3b regulates TBK1 in the virus-
triggered IRF3 activation pathway. In our earlier experiments,
we demonstrated that the kinase inactive mutant of GSK3b
could complement virus-triggered IFN-b induction to a level
comparable to its wild-type or constitutive active counterpart
(Figure 3). These results suggest that the kinase activity of
GSK3b is not required for its regulation of TBK1-mediated
signaling. We therefore determined whether GSK3b regulates
TBK1 dimerization or oligomerization and autoactivation. In tran-
sient transfection and coimmunoprecipitation experiments,
GSK3b markedly enhanced TBK1 self-association (dimerization
or oligomerization) (Figure 5A). The effect of GSK3b on TBK1
self-association was independent of its kinase activity, because
both GSK3b(S9A) and GSK3b(K85A) had similar effects (Fig-
ure 5A). In contrast, overexpression of GSK3b did not affect
TBK1-IKK3, TBK1-MITA, or VISA-MITA interactions (Figure S4).IThese data suggest that GSK3b promotes TBK1 self-association
independent of its kinase activity.
During our immunoprecipitation assays, we observed that
transfection of GSK3b caused a shift of TBK1 but not IKK3 to
higher molecular weight bands (Figures 5B and 5C). Such a shift
was due to phosphorylation of TBK1 as shown by the fact that
calf intestine phosphatase (CIP) treatment diminished the shift
(Figure 5B). Interestingly, GSK3b-mediated phosphorylation of
TBK1 was independent of the kinase activity of GSK3b because
both the kinase inactive mutant GSK3b(K85A) and the constitu-
tive active mutant GSK3b(S9A) similarly enhanced phosphoryla-
tion of TBK1 (Figure 5B). Because GSK3b enhanced TBK1 self-
association and phosphorylation independent of the kinase
activity of GSK3b, we reasoned that GSK3b promotes TBK1
autophosphorylation. As shown in Figure 5D, overexpression
of GSK3b caused phosphorylation of wild-type TBK1 but not
TBK1(K38A), a kinase inactive mutant in which the ATP binding
residue Lys38 was mutated to alanine. These results suggest
that GSK3b mediates TBK1 dimerization or oligomerization
and autophosphorylation independently of the kinase activity
of GSK3b.
TBK1 Autophosphorylation at Ser172 Is Essential
for Virus-Triggered Signaling
Having established that GSK3bmediates TBK1 self-association
and autophosphorylation, we next determined which amino acid
residues of TBK1 are autophosphorylated. We made a series of
mutants of TBK1 in which potential phosphorylation residues
predicted by the NetPhos program were mutated to alanines
individually (partially shown in Figure S5A). In reporter assays,
mutation of Ser172 but not other serines or threonines to alanine
impaired the ability of TBK1 to activate ISRE and the IFN-b
promoter (Figures 6A and 6B; Figure S5A). TBK1(S172A), similar
to the kinase inactive mutant TBK1(K38A), could act as a domi-
nant-negative mutant to inhibit SeV-induced activation of ISRE
and the IFN-b promoter (Figures 6A and 6B). GSK3b failed to
cause phosphorylation of TBK1(S172A) whereas in the same
experiments GSK3b mediated phosphorylation of wild-type
TBK1and a randomized serinemutant, TBK1(S716A) (Figure 6C).
To determine whether GSK3b promotes TBK1 autophosphoryla-
tion or trans-phosphorylation at Ser172, we transfected 293 cells
with Flag-tagged wild-type or mutant TBK1, HA-tagged wild-
type TBK1 and GSK3b, or control plasmid. Flag-tagged TBK1
and mutants were pulled down by coimmunoprecipitation with
anti-Flag. Immunoblot analysis with anti-pSer172TBK1, an anti-
body that specifically recognizes Ser172-phosphorylated
TBK1, indicated that GSK3b increased phosphorylation of
Flag-tagged wild-type TBK1 and TBK1(S716A) but not TBK1
(K38A) or TBK1(S172A) at residue 172 even in the presence of
HA-tagged wild-type TBK1 (Figure 6D). These results suggest
that GSK3b promotes autophosphorylation but not trans-phos-
phorylation of TBK1 at Ser172. TBK1 phosphorylation is not
a prerequisite for its self-association as shown by the fact that
TBK1(S172A) and TBK1(K38A) as well as wild-type TBK1
self-associate (Figure S5B). Although TBK1(S172A) and TBK1
(K38A) acted as dominant-negative mutants to inhibit SeV-
induced activation of ISRE and the IFN-b promoter (Figures 6A
and 6B), they did not inhibit phosphorylation of wild-type TBK1
(Figure S5C). The simplest explanation for these observationsmmunity 33, 878–889, December 22, 2010 ª2010 Elsevier Inc. 881
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Figure 2. Knockdown of GSK3b Inhibits Virus-Triggered Activation of IRF3 and Transcription of the IFNB1 Gene
(A) Effects of GSK3b RNAi plasmids on the expression of transfected and endogenous GSK3b. In the upper panel, 293 cells (2 3 105) were transfected with
expression plasmids for HA-GSK3b and HA-USP2 (0.1 mg each) and the indicated RNAi plasmids (2 mg). 24 hr after transfection, cell lysates were analyzed
by immunoblot with anti-HA. In the bottom panels, 293 cells (2 3 105) were transfected with control or the indicated GSK3b RNAi plasmids (2 mg each) for
24 hr. Cell lysates were then analyzed by immunoblots with the indicated antibodies.
(B) Effects ofGSK3bRNAi plasmids onSeV-inducedactivation of the IFN-bpromoter and ISRE. 293 cells (13105)were transfectedwith the indicatedGSK3bRNAi
(0.5 mg) and the reporter (0.1 mg) plasmids. 24 hr after transfection, cells were left uninfected or infectedwith SeV for 12 hr before luciferase assayswere performed.
(C) Effects ofGSK3bRNAi plasmidsonSeV-induced expressionof downstreamgenes. 293cells (23105)were transfectedwith control orGSK3bRNAi plasmids (2
mg). 24 hr after transfection, cells were left uninfected or infected with SeV for 10 hr before RT-PCR was performed.
(D) Knockdown of GSK3b inhibits SeV-induced IRF3 dimerization and phosphorylation. 293 cells (23 105) were transfected withGSK3bRNAi plasmid (2 mg). 24 hr
after transfection, cells were infected with SeV or left uninfected for 8 hr. Cell lysates were separated by native (top) or SDS (bottom three panels) PAGE and
analyzed with the indicated antibodies.
(E) Effects ofGSK3bRNAiplasmidson IFN-g-inducedactivation of the IRF1promoter. 293cells (13105)were transfectedwith the indicatedGSK3bRNAiplasmids
(0.5 mg) and the IRF1 reporter plasmid (0.1 mg). 24 hr after transfection, cells were left untreated or treated with IFN-g (100 ng/ml) for 12 hr before luciferase assays
were performed.
(F) Effects of GSK3b knockdown on cytoplasmic poly(I:C)-induced activation of ISRE and the IFN-b promoter. 293 cells (13 105) were transfected with control or
GSK3b RNAi plasmid (#1) (0.5 mg) and the indicated reporter plasmids (0.1 mg). 24 hr after transfection, cells were mock-transfected or transfected with poly(I:C)
(1 mg) with Lipofectamine 2000 for 12 hr before luciferase assays were performed.
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GSK3b Regulates TBK1 Activity and IFN-b Inductionis that these TBK1mutants bind to IRF3 and inhibit its phosphor-
ylation by endogenous TBK1 after viral infection, thereby inhibit-
ing virus-induced IRF3 activation and IFN-b induction.
We further examined phosphorylation of endogenous TBK1 in
the absence or presence of viral infection. Although the basal
phosphorylation of Ser172 of TBK1 in Gsk3b/ MEFs was
slightly higher than wild-type MEFs, SeV infection induced
increased phosphorylation of TBK1 at Ser172 in wild-type but
not Gsk3b/ MEFs (Figure 6E). Taken together, these results
suggest that GSK3b mediates virus-induced TBK1 autophos-
phorylation at Ser172 and that this phosphorylation is critical
for TBK1-mediated IRF3 activation and IFN-b induction.
GSK3b Is Required for Virus-Triggered Activation
of NF-kB
Transcription inductionof IFN-b requirescoordinatedandcooper-
ative activation of both the transcription factors IRF3 and NF-kB.
Previous studies have demonstrated that GSK3b is required for
NF-kB binding to its consensus enhancer motifs (Hoeflich et al.,
2000). We performed experiments to determine whether GSK3b
plays a role in virus-triggeredNF-kBactivation. In reporter assays,
knockdown of GSK3b dramatically inhibited SeV-induced NF-kB
activation (Figure 7A). Knockdown of GSK3b also inhibited NF-kB
activation mediated by overexpression of VISA and TRIF, sug-
gesting that GSK3b is important for both RIG-I and MDA5 and
TLR3-mediated NF-kB activation (Figure 7C). Moreover, SeV-
induced IkBa phosphorylation and degradation were markedly
impaired in Gsk3b/ MEFs (Figure 7B). Previously, it has been
shown that GSK3b is not required for TNF- and IL-1-induced
IkBa phosphorylation and degradation and for NF-kB transloca-
tion into the nucleus but is required for NF-kB binding to its target
sequences (Hoeflich et al., 2000). We confirmed these observa-
tions withGsk3b/MEFs. We found that TNF- and IL-1-induced
IkBa degradation were unaffected, but NF-kB-mediated tran-
scription was impaired in Gsk3b/ MEFs (Figures 7D and 7E).
These results suggest that GSK3b is required for virus-triggered
NF-kB activation through mechanisms distinct from TNF- and
IL-1-induced NF-kB activation.
DISCUSSION
GSK3b is a ser-thr kinase originally identified as a key enzyme
involved in the glycogen synthesis. Subsequent studies suggest
that GSK3b targets dozens of substrates involved in diverse
cellular processes, such as metabolism, cell cycle, transcription
regulation, vesicular transport, neuronal function, oncogenesis,
and development (Jope and Johnson, 2004). Because of the
diverse processes in which GSK3b is involved, efforts have
been focusing on developing GSK3b inhibitors for various
diseases such as diabetes, Alzheimer’s disease, osteoporosis,
cancer, and inflammatory diseases. In this study, we found(G) Effects of GSK3b knockdown on poly(dA:dT)-induced activation of ISRE and t
(dA:dT) was transfected instead of poly(I:C).
(H) Effects of knockdown of GSK3b on TLR3-mediated activation of ISRE and the
plasmid (0.5 mg) and the indicated reporter plasmids (0.1 mg). 24 hr after transfect
luciferase assays were performed.
Graphs show mean ± SD, n = 3. *p < 0.05; **p < 0.01. See also Figure S2.
Ithat GSK3b is essential for virus-triggered IRF3 and NF-kB acti-
vation, IFN-b induction, and cellular antiviral response. Unlike
most circumstances in which its functions are mediated by its
kinase activity, the involvement of GSK3b in virus-triggered
IRF3 activation and IFN-b induction is independent of its kinase
activity. Instead, GSK3b mediates dimerization or oligomeriza-
tion and autophosphorylation of TBK1, a kinase responsible for
phosphorylating IRF3 after viral infection. The present study
establishes an important role for GSK3b in virus-triggered IFN
induction and cellular antiviral response and provides a mecha-
nistic explanation on how TBK1 is activated after viral infection.
Overexpression of GSK3b potentiated virus-triggered activa-
tion of IRF3 and expression of the IFNB1 gene. Conversely,
RNAi-mediated knockdown of GSK3b markedly inhibited virus-
triggered activation of IRF3 and induction of the IFNB1 gene.
Consistently, Gsk3b/ MEFs showed impaired IRF3 activation
and Ifnb1 gene expression after viral infection, and reconstitution
of GSK3b markedly restored the ability of these cells to activate
ISRE and the IFN-b promoter in response to viral infection. More-
over, Gsk3b/ exhibited increased viral replication upon VSV
infection, suggesting that GSK3b is required for efficient cellular
antiviral response.
Phosphorylation by GSK3b results in inhibition of many of its
substrates (Jope and Johnson, 2004). For example, phosphory-
lation of c-Jun, AP-1, or CREB by GSK3b negatively regulates
the DNA binding activities of these transcription factors
(Hu et al., 2006). We therefore performed several experiments
to test whether the kinase activity of GSK3b is required for its
ability to potentiate virus-triggered IRF3 activation and IFN-b
induction. First, both the constitutively active mutant GSK3b
(S9A) and the inactive mutant GSK3b(K85A) enhanced virus-
induced activation of IRF3 and the IFN-b promoter as wild-type
GSK3b did in reporter assays. Second, inhibition of the kinase
activity of GSK3b by its specific inhibitor SB216763 did not affect
virus-triggered activation of IRF3 (data not shown). Third, recon-
stitution ofGsk3b/MEFswith kinase inactivemutant of GSK3b
restored SeV-induced IFN-b expression and antiviral activity to
similar degrees as with wild-type GSK3b. Fourth, overexpres-
sion of wild-type GSK3b, GSK3b(S9A), or GSK3b(K85A) caused
TBK1 self-association and autophosphorylation to similar
degrees. These findings suggest that the involvement of
GSK3b in virus-triggered IRF3 activation and IFN-b induction is
independent of its kinase activity. Although this finding is inter-
esting and intriguing, it is not totally unexpected. GSK3b has
been shown to inhibit E2F1 transcriptional activity and neural
cell differentiation independent of its kinase activity (Zhou
et al., 2008). Other ser-thr kinases have also exhibited kinase
activity-independent functions. For example, RIP1, a ser-thr
kinase required for TNF receptor I-mediated NF-kB activation,
acts in a kinase activity-independent way in this process
(Hsu et al., 1996).he IFN-b promoter. The experiments were performed as in (G) except that poly
IFN-b promoter. 293-TLR3 cells were transfected with control or GSK3b RNAi
ion, cells were left untreated or treated with poly(I:C) (25 mg/ml) for 12 hr before
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Figure 3. GSK3b Deficiency Impairs Virus-Triggered IRF3 Activation, IFN-b Induction, and Cellular Antiviral Response
(A) SeV-triggered activation of the IFN-b promoter is impaired in GSK3b/ MEFs. Gsk3b+/+ and Gsk3b/ MEFs were transfected with the IFN-b promoter
reporter plasmid (0.2 mg). 24 hr later, cells were left uninfected or infected with SeV for 12 hr before luciferase assays were performed.
(B) SeV-triggered transcription of the Ifnb1 gene is impaired in Gsk3b/ MEFs. Gsk3b+/+ and Gsk3b/ MEFs were left uninfected or infected with SeV for the
indicated times before RT-PCR was performed.
(C) SeV-triggered activation of ISRE is impaired in GSK3b/ MEFs. The experiments were done as in (A).
(D) SeV-induced IRF3 activation is impaired in Gsk3b/ MEFs. Gsk3b+/+ and Gsk3b/ MEFs were left uninfected or infected with SeV for the indicated times.
Cell lysates were separated by native (top) or SDS (bottom two panels) PAGE and analyzed with the indicated antibodies.
(E) Transduction of GSK3b but not GSK3a into Gsk3b/ MEFs markedly restores SeV-induced activation of the IFN-b promoter. Gsk3b/ MEFs were recon-
stituted with GSK3b or GSK3a by retrovirus-mediated gene transfer. The reconstituted cells were transfected with the IFN-b promoter reporter (0.2 mg) for 16 hr
and then left uninfected or infected with SeV for 12 hr before luciferase assays were performed. Expression of the transduced proteins was detected by
immunoblot with anti-HA (for GSK3b) and anti-Flag (for GSK3a).
(F) Complementation of Gsk3b/MEFs with the GSK3bmutants restores their responses to SeV-induced activation of the IFN-b promoter and ISRE. Gsk3b/
MEFs were reconstituted with GSK3b or its mutants by retrovirus-mediated gene transfer. The reconstituted cells were transfected with the IFN-b promoter or
ISRE reporter (0.2 mg) for 16 hr, and then left uninfected or infected with SeV for 12 hr before luciferase assays were performed. Expression of the transduced
proteins was detected by immunoblot with anti-GSK3b.
(G) Complementation of Gsk3b/ MEFs with GSK3b and its mutants restores their responses to SeV-induced transcription of the Ifnb1 gene. Gsk3b/ MEFs
were reconstituted as in (E) and left uninfected or infected with SeV for 8 hr before real-time PCRs were performed.
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Figure 4. GSK3b Mediates Virus-Triggered Signaling at the TBK1 Level
(A) Knockdown of GSK3b inhibits VISA-, MITA-, and TBK1- but not IRF3(5D)-mediated ISRE activation. 293 cells (13 105) were transfected with control or GSK3b
RNAi plasmid (#1) (0.5 mg). 20 hr later, the cells were further transfected with the indicated plasmids (0.1 mg each). Reporter assays were performed 24 hr after
transfection.
(B) Deletion of GSK3b impairs RIG-I-, VISA-, and TBK1- but not IRF3(5D)-mediated ISRE activation. Gsk3b+/+ and Gsk3b/ MEFs were transfected with the
indicated plasmid (0.2 mg each) for 24 hr before reporter assays were performed.
(C) Knockdown of GSK3b inhibits TRIF-mediated activation of ISRE and the IFN-b promoter. The experiments were performed as in (A).
(D) GSK3b potentiates TBK1- but not IKK3-mediated ISRE activation. 293 cells (13 105) were transfected with the indicated plasmids for 24 hr before luciferase
assays were performed.
(E) GSK3b interacts with TBK1 but not IKK3. 293 cells were transfected with the indicated plasmids. Coimmunoprecipitation was performed with anti-Flag or
control IgG. The immunoprecipitates were analyzed by immunoblot with anti-HA (top). The lysates were analyzed by immunoblots with anti-Flag or anti-HA
(bottom).
(F) GSK3b is associated with TBK1 in a viral infection-dependent manner. 293 cells (1 3 108) were left uninfected or infected with SeV for the indicated times.
A small fraction of the cells (1 3 106) were prepared for RT-PCR (bottom panels). The other cells were lysed and the lysates were immunoprecipitated with
anti-TBK1 or preimmune serum. The immunoprecipitates were analyzed by immunoblot with anti-GSK3b or anti-TBK1 (top). The expression levels of the endog-
enous GSK3b, TBK1, and b-actin were detected by immunoblot analysis (middle).
Graphs show mean ± SD, n = 3. *p < 0.05; **p < 0.01. See also Figure S3.
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GSK3b Regulates TBK1 Activity and IFN-b InductionOur experiments suggest that GSK3b is involved in virus-trig-
gered IRF3 activation and IFN-b induction by targeting TBK1.
Knockdown or deletion of GSK3b impaired IRF3 activationmedi-(H) GSK3b plays an important role in cellular antiviral response. Wild-type orGsk3
cated. The cells were then transfected with poly(I:C) or mock transfected for 12 h
vested 24 hr after infection and used for standard plaque assays.
Graphs show mean ± SD, n = 3. *p < 0.05; **p < 0.01.
Iated by overexpression of TBK1 or its upstream components
such as RIG-I, VISA, and MITA but not downstream component
IRF3. Coimmunoprecipitation experiments indicated that GSK3bb/MEFs were reconstituted with control, GSK3b, or GSK3bmutants as indi-
r before cells were infected with VSV (MOI = 0.1). The supernatants were har-
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Figure 5. GSK3b Promotes TBK1 Self-Association and Autophosphorylation
(A) GSK3b and its mutants promote TBK1 self-association. 293 cells (23 106) were transfected with the indicated plasmids (5 mg each). Coimmunoprecipitations
were performed with anti-Flag. Immunoblot analysis was performed with anti-HA or anti-Flag (top). Expression levels of the transfected plasmids were confirmed
by immunoblot analysis of the lysates with anti-HA (bottom).
(B) GSK3b and its mutants promote phosphorylation of TBK1. 293 cells (2 3 106) were transfected with the indicated plasmids (6 mg each). Cell lysates were
immunoprecipitated with anti-Flag. The immunoprecipitates were treated with buffer or calf intestine phosphatase (CIP) and analyzed by immunoblot with
anti-Flag (top). Expression of the transfected proteins was analyzed by immunoblot with anti-HA (bottom).
(C) GSK3b and its mutants do not promote phosphorylation of IKK3. The experiments were performed as in (B).
(D) GSK3b promotes phosphorylation of wild-type but not kinase-inactive TBK1. The experiments were performed as in (B).
See also Figure S4.
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GSK3b Regulates TBK1 Activity and IFN-b Inductionwas associatedwith TBK1 in a viral infection-dependentmanner.
In overexpression system, GSK3b, as well as its kinase inactive
mutant GSK3b(K85A), promoted dimerization or oligomerization
and autophosphorylation of TBK1 at Ser172. However, GSK3b
was incapable of promoting autophosphorylation of TBK1
(K38A), the kinase inactive mutant of TBK1. Studies with
Gsk3b/ MEFs indicated that GSK3b was required for virus-
triggered phosphorylation of TBK1 at Ser172. Mutation of
Ser172 to alanine abolished the ability of TBK1 to activate IRF3
and this mutant acted as a dominant-negative mutant to inhibit
virus-triggered activation of IRF3 and the IFN-b promoter. Taken
together, our results suggest a model on the role of GSK3b in
virus-triggered IRF3 activation pathway in which GSK3b is
recruited to TBK1 and mediates TBK1 dimerization or oligomer-
ization after viral infection. This step promotes TBK1 autophos-
phorylation at Ser172 and in turn phosphorylates IRF3.
Currently, how viral infection causes association of TBK1 and
GSK3b is unknown. In cell fractionation experiments, GSK3b
was localized in all fractions examined, including the cytosol,
mitochondria, and the ER fractions, and this distribution was
not significantly affected by viral infection (data not shown).
It is possible that viral infection causes recruitment of TBK1 to
the VISA-associated complex, which then causes conforma-
tional changes or post-translational modifications of TBK1 and
these provide high-affinity binding sites for GSK3b. Alternatively,
virus infection may signal conformational changes, posttransla-
tion modifications, or binding partner changes of GSK3b, result-
ing in its recruitment to TBK1-associated complex.886 Immunity 33, 878–889, December 22, 2010 ª2010 Elsevier Inc.Endogenous coimmunoprecipitation experiments indicated
that the interaction between GSK3b and TBK1 could be seen
at 4 hr after SeV infection. However, the interaction reached
maximum at 8–12 hr after SeV infection. Because deletion of
GSK3b markedly impaired but did not completely abolish IRF3
activation and IFN-b induction after SeV infection, it is also
possible that GSK3b is involved in an amplification cascade of
virus-induced interferon induction through a virally induced
complex rather than being required for the first wave of produc-
tion of virus-induced interferons.
In addition to virus-triggered RLR-mediated IRF3 activation
pathways, our study also demonstrated that GSK3b is required
for TLR3- and TLR4-mediated IFN-b induction. This is consistent
with the notion that IRF3 activation pathways triggered by
various RLRs and TLRs converge at TBK1, which is targeted
by GSK3b. Previously, it has been been shown that knockdown
of GSK3b by RNAi or inhibitors decreased LPS-induced TNF
production but increased LPS-induced IFN-b and IL-10 produc-
tion in monocytes or macrophages (Martin et al., 2005; Wang
et al., 2008). The reasons behind the discrepancy between our
and the reported findings are unknown. Recently, it has been
reported that the leucine-rich repeat domain-containing protein
LRRFIP1, which is capable of recognizing viral and bacterial
nucleic acids, mediates interferon production through a b-cate-
nin-IRF3-dependent pathway (Rathinam et al., 2010; Yang et al.,
2010). b-catenin is destabilized in an ubiquitination-proteasome-
dependent manner by a destruction complex containing casein
kinase Ia (CKIa), GSK3b, adenomatous polyposis coli (APC),
AC
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Figure 6. GSK3b-Mediated Phosphoryla-
tion of TBK1 at Ser172 Is Required for
Virus-Triggered IRF3 Activation and IFN-b
Induction
(A and B) Ser172 of TBK1 is critical for SeV-trig-
gered activation of ISRE (A) and the IFN-bpromoter
(B). 293 cells (13 105) were transfected with ISRE
(A) or the IFN-b promoter (B) reporter plasmid
(0.1 mg) and expression plasmids for TBK1 and
its mutants (0.1 mg). 20 hr after transfection, cells
were infected with SeV or left uninfected for 12 hr
before luciferase assays were performed.
(C) GSK3b does not promote phosphorylation of
TBK1(S172A). 293 cells (23 106) were transfected
with the indicated plasmids (6 mg each). Cell
lysates were immunoprecipitated with anti-Flag.
The immunoprecipitates were treated with buffer
or CIP and analyzed by immunoblot with anti-
Flag (top). Expression of GSK3b and its mutants
were analyzed by immunoblot with anti-HA
(bottom).
(D) The effects of GSK3b on phosphorylation of
TBK1 and its mutants at residue 172. 293 cells
(2 3 106) were transfected with the indicated plas-
mids (6 mg each). Cell lysates were centrifuged at
13,000 rpmfor10min.Thesupernatantsweredena-
tured by 1% SDS and heated for 5 min. The super-
natants were diluted with regular lysis buffer until
the concentration of SDS was decreased to 0.1%.
The diluted supernatants were immunoprecipitated
with anti-Flag. The immunoprecipitates were
analyzed by immunoblot with anti-pSer172TBK1
(top). The expression levels of the transfected
proteins were detected by anti-Flag and anti-HA,
respectively.
(E) Impairment of virus-induced phosphorylation of
TBK1 at Ser172 in GSK3b-deficient MEFs.
Gsk3b+/+ and Gsk3b/ MEFs were left uninfected
or infected with SeV for the indicated times. Cell
lysateswereanalyzedwith the indicatedantibodies.
Graphs showmean ± SD, n = 3. **p < 0.01. See also
Figure S5.
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GSK3b Regulates TBK1 Activity and IFN-b Inductionand Axin (Ha et al., 2004). Whether and how the classical TBK1-
IRF3 and the newly identified b-catenin-IRF3 pathways cross-
talk through GSK3b remains to be investigated. One potential
hypothesis is that microbial infection recruits GSK3b to TBK1
from the b-catenin destruction complex, thereby promoting acti-
vation of both the TBK1-IRF3 and the b-catenin-IRF3 pathways.
Virus-triggered transcription induction of type I IFNs requires
coordinated actions of transcription factors IRF3 and NF-kB.
We found that ablation of GSK3b expression severely impaired
virus-triggered IkBa phosphorylation and degradation as well
as NF-kB-mediated transcription. GSK3b is not required for
TNF- and IL-1-induced IkBa phosphorylation and degradation
and for NF-kB translocation into the nucleus, but is required
for NF-kB binding to its consensus enhancer motifs (Hoeflich
et al., 2000). Although our data could not tell whether GSK3b is
required for NF-kB binding to its consensus DNA motifs after
viral infection, they suggest that GSK3b is required for virus-
and for TNF- and IL-1-triggered NF-kB activation pathways
through distinct mechanisms. Although the exact mechanisms
of GSK3b-mediated NF-kB activation in the virus-triggered
signaling pathways require further investigations, our studiesIsuggest that GSK3b regulates both virus-triggered IRF3 and
NF-kB activation pathways. The establishment of a regulatory
role for GSK3b in virus-triggered IRF3 and NF-kB activation
contributes to the elucidation of the complicated molecular
mechanisms of cellular antiviral response.
EXPERIMENTAL PROCEDURES
Reagents
Mouse monoclonal antibodies against Flag, HA, and b-actin (Sigma),
phospho-TBK1(Ser-172) (BD Biosciences), and phospho-IRF3 (Ser396)
(Upstate); rabbit polyclonal antibodies against IRF3 (Santa Cruz Biotech-
nology); and 293-TLR4-MD2-CD14 cells (Invitrogen) were purchased from
the indicated manufacturers. SeV and VSV were previously described (Zhong
et al., 2008, 2009). Mouse anti-TBK1 and mouse anti-GSK3b antisera were
raised against recombinant human TBK1(1–320) and human full-length
GSK3b, respectively. Gsk3b/ and wild-type MEFs (J. Woodgett, Ontario
Cancer Institute) and 293-TLR3 (K. Fitzgerald, University of Massachusetts)
were provided by the indicated investigators.
Constructs
NF-kB, ISRE, the IFN-b, and IRF1 promoter luciferase reporter plasmids,
mammalian expression plasmids for HA- or Flag-tagged RIG-I, VISA, MITA,mmunity 33, 878–889, December 22, 2010 ª2010 Elsevier Inc. 887
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Figure 7. GSK3b Is Required for Virus-Triggered Activation of NF-kB
(A) Effects of GSK3bRNAi plasmids on SeV-induced NF-kB activation. 293 cells (13 105) were transfected with GSK3b RNAi (0.5 mg) and NF-kB reporter (0.1 mg)
plasmids. 24 hr after transfection, cells were left uninfected or infected with SeV for 12 hr before luciferase assays were performed. Graphs show mean ± SD,
n = 3. **p < 0.01.
(B) SeV-induced IkBa phosphorylation and degradation was impaired in GSK3b-deficient MEFs. Gsk3b+/+ and Gsk3b/ MEFs were left uninfected or infected
with SeV for the indicated times. Cell lysates were analyzed by immunoblot with the indicated antibodies.
(C) Knockdown of GSK3b inhibits VISA- and TRIF-mediated NF-kB activation. 293 cells were transfected with GFP or GSK3b RNAi construct and selected with
puromycin for 2 days. The cells were then transfected with NF-kB reporter plasmid and expression plasmid for VISA or TRIF. Reporter assays were performed
24 hr after transfection.
(D) GSK3b is not required for TNF- and IL-1-induced IkBa degradation. Wild-type andGsk3b/MEFs were treated with TNF (10 ng/ml) or IL-1 (10 ng/ml) for the
indicated times. Cell lysates were analyzed by immunoblots with the indicated antibodies.
(E) GSK3b is essential for NF-kB-mediated transcription-induced TNF and IL-1.Wild-type andGsk3/MEFswere transfectedwith a NF-kB reporter plasmid and
then treated with TNF (10 ng/ml) or IL-1 (10 ng/ml) for 10 hr before luciferase reporter assays were performed.
Immunity
GSK3b Regulates TBK1 Activity and IFN-b InductionTRIF, IKK3, and TBK1were previously described (Zhong et al., 2008). Mamma-
lian expression plasmids for human GSK3a and GSK3b were purchased from
Origene company. GSK3b-HA-pcDNA and its mutants (J. Woodgett, Ontario
Cancer Institute), the expression plasmid for IRF3(5D) (J. Hiscott and R. Lin,
McGill University) were provided by the indicated investigators. Flag- and
HA-tagged GSK3a, GSK3b and its mutants and TBK1 mutants were also con-
structed in the retroviral vector MIGR1 that contains a GFP or puromycin
marker (provided by Z. Huang, Wuhan University).
Transfection and Reporter Gene Assays
The 293 cells (1 3 105) were seeded on 24-well plates and transfected the
following day by standard calcium phosphate precipitation. MEFs were trans-
duced by Lipofectamine 2000 (Promega). In the same experiment, empty
control plasmid was added to ensure that each transfection receives the
same amount of total DNA. To normalize for transfection efficiency, 0.01 mg
of pRL-TK Renilla luciferase reporter plasmid was added to each transfection.
Luciferase assays were performed with a dual-specific luciferse assay kit
(Promega). Firefly luciferase activities were normalized based on Renilla lucif-
erase activities.888 Immunity 33, 878–889, December 22, 2010 ª2010 Elsevier Inc.Retrovirus-Mediated Gene Transfer
The packaging cell line Plat-E was transfected with the retroviral vectors by
calcium phosphate precipitation. 12 hr later, cells were washed and new
medium without antibiotics was added for 24 hr. The supernatant was filtered
and used to infect wild-type orGsk3b/MEFs in the presence of 4 mg/ml pol-
ybrene. The infection was repeated twice so that the transduction efficiency
reached at least 90% as monitored by expression of GFP.
Coimmunoprecipitation, Immunoblot Analysis, Native PAGE,
and RT-PCR
These experiments were performed as described (Xu et al., 2005; Zhong et al.,
2008).
VSV Plaque Assays
Wild-type and GSK3b/ MEFs were tranduced with GSK3a, GSK3b, and its
mutants by retrovirus-mediated gene transfer method. The cells were grown
in 24-well plate dishes and transfected by Lipofactamine with poly(I:C) (1 mg)
or control buffer for 24 hr prior to VSV infection. At 1 hr postinfection, cells
were washed with PBS and then fresh medium was added. The supernatant
Immunity
GSK3b Regulates TBK1 Activity and IFN-b Inductionwas harvested 24 hr later and used to infect confluent BHK21 cells cultured.
Plaque assays were then performed as described (Zhong et al., 2008).
RNAi
Double-strand oligonucleotides corresponding to the target sequences were
cloned into the pSuper.Retro RNAi plasmid (Oligoengine Inc.). The following
sequences were targeted for human GSK3b cDNA: GSK3b-RNAi #1, aagaatc-
gagagctccaga; #2, aagtaatccacctctggct.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.immuni.2010.11.021.
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